ValiRx - VAL201 Update
VAL
Wed, 11 Sep 2019, 04:10pm BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
ValiRx announces that in addition to pharmacokinetic and toxicology data, clinical trial results show VAL201 behaves as predicted in reducing prostate cancer progression. Dr George Morris, COO, discusses the significance of this announcement and the next stage of development.